Author:
Terpos Evangelos,Kanellias Nikolaos,Raje Noopur
Publisher
Springer International Publishing
Reference244 articles.
1. Abe M, Hiura K, Wilde J et al (2004) Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion. Blood 104(8):2484–2491
2. Agrillo A, Filiaci F, Ramieri V et al (2012) Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy. Eur Rev Med Pharmacol Sci 16(12):1741–1747
3. Alongi P, Zanoni L, Incerti E et al (2015) 18F-FDG PET/CT for early post-radiotherapy assessment in solitary bone plasmacytomas. Clin Nucl Med 40:e399–e404
4. Anderson G, Gries M, Kurihara N et al (2006) Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1. Blood 107(8):3098–3105
5. Aparicio A, Gardner A, Tu Y et al (1998) In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates. Leukemia 12:220
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献